Potential biomarkers were figured out from three time-points by multivariate statistical and integration analyses.
Two metabolic pathways related to cyclophosphamide were identified by metabolomics.
ROC curve was used to validate the rationality of the biomarkers.
Metabolomics technology provides a strategy for research on mechanism of CYinduced cardiotoxicity.